The study projects the market to grow at a CAGR of 14.98% between 2022 and 2032
BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Cell-Free RNA Isolation and Extraction Kits Market – A Global and Regional Analysis.
According to this study, the global cell-free RNA isolation and extraction kits market size was $30.2 million in 2021 and is projected to reach $140.7 million by 2032.
The following factors are responsible for the increase in demand for cell-free RNA isolation and extraction kits:
- Increasing incidence of cancer
- Increasing number of cases with prenatal complications
- Advancements in the RNA sequencing technology
The detailed study is a compilation of 06 market data tables and 78 figures spread through 132 pages.
Check out the detailed table of content here
Analyst’s Take on the Market Projection
According to Nitish Kumar, Principal Analyst, BIS Research, “Global cell-free RNA isolation and extraction kits market has gained momentum recently. The increase in research activities and funding to promote the utilization of cell-free RNA for early detection of a disease condition and decipher insights to provide personalized treatment to patients would enable the market to propel during the forecast period 2022-2032.”
Make an inquiry before buying à https://bisresearch.com/contact-us
Existing Competitive Landscape
The companies that are profiled have been selected based on primary research inputs gathered from a network of industry experts and analyzing company coverage, product portfolio, and market penetration.
Some of the prominent established names in this market are:
- Aline Biosciences
- Apostle Sciences
- Danagen-Bioted, S.L.
- Hoffmann-La Roche Ltd.
- JBS Science Inc.
- Norgen Biotek Corp.
- PerkinElmer, Inc.
- Promega Corporation
- QIAGEN N.V.
- Streck, Inc.
- Thermo Fisher Scientific Inc.
- Takara Bio Inc.
- Zymo Research Corporation
Recent Developments in the Global Cell-Free RNA Isolation and Extraction Kits Market
In February 2022, Zinexts Life Science Corp. and JBS Science, Inc. entered into a technology commercialization cooperation agreement to allow Zinexts to manufacture and sell JBS nucleic separation kits, including cfDNA and RNA isolation kits. This license agreement will make it easier to access JBS NA Zinexts’s JBS NA isolation equipment and their isolation automation systems.
Oncology to Continue as the Leading Application During the Forecast Period of 2022-2032
Cell-free RNA (cfRNA) naturally occurs in cell-free fluids and represents an opportunity to detect tumors in patients with lower tumor shedding rates. It is involved in cell communications and has been linked to physical and pathological conditions. It has increasingly gained prominence as a biomarker for liquid biopsy in cancer patients in order to deliver personalized therapy.
The oncology segment accounted for the largest share in the global cell-free RNA isolation and extraction kits market in 2021. This is primarily due to the growing use of cell-free RNA-based biomarkers for cancer diagnosis and these technologies’ utilization in several cancer-based research initiatives.
As per the study by BIS Research, this trend is expected to continue during the forecast period of 2022-2032.
However, interestingly, it is the application of prenatal screening (preeclampsia) which is projected to see the highest growth rate during the same forecast period.
Why Should You Buy The Report?
This exclusive report on the global cell-free RNA isolation and extraction kits market will help in the following ways:
- Offers detailed information on the future perspective of the emerging as well as established players
- Offers go-to-market strategies for the different source type
- Supports diversifying the product portfolio based on risk and progression of application in the global cell-free RNA isolation and extraction kits market
- Helps in analyzing technological substitutes and comparing the specification of various ecosystems and applications
- Offers tailor-made solutions based on the throughput of different consumers
- Assists in exploring the newer application
- Supports in analyzing the competitors’ funding scenario
- Aids in understanding the new trends in the cell-free RNA isolation and extraction kits industry
Request a FREE sample of this report here à
BIS Research Related Market Studies:
About BIS Research:
BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends which can disrupt the market dynamics in the near future. We publish more than 200 market intelligence studies annually that focus on several deep technology verticals.
Our strategic market analysis emphasizes on market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.
BIS Research offers syndicate as well as custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscape.
Email: [email protected]
BIS Research Inc.
39111 PASEO PADRE PKWY STE 313,
FREMONT CA 94538-1686
Visit our Blog @ https://bisresearch.com/news
Get Expert Insights @ https://community.insightmonk.com
Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research